4.599USD-1.94%Mkt Cap: 119.66M USDP/E: —Last update: 2026-06-01
NeOnc Technologies Holdings, Inc., a clinical-stage biopharmaceutical company, focuses on developing treatments for intracranial malignancies. Its lead product candidates include NEO100, a purified form of preillyl acid …
Industry Peers
Biotechnology111.39BUSDP/E 26.0
100.62BDKKP/E 19.4
62.97BUSDP/E 14.7
48.39BEURP/E 31.7
44.65BEURP/E 37.2
40.10BUSDP/E 75.3
35.22BUSD—
32.91BSEKP/E 48.6
Indicators:|
Key Statistics
Company
Market Cap119.66M USD
Enterprise Value118.94M USD
Revenue (TTM)0 USD
Gross Profit0 USD
Net Income (TTM)-62.15M USD
Revenue/Share0.0000 USD
Last Price4.599 USD
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees5
CountryUS
SectorHealthcare
IndustryBiotechnology
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)-6.16
PEG—
EV/EBITDA—
EV/Revenue—
P/SInfinity
P/B-8.47
EPS (TTM)-1.80
EPS (Forward)-0.75
52W Range
3.20014% of range12.99
52W High12.99 USD
52W Low3.200 USD
Profitability
Gross Margin0.00%
Oper. Margin0.00%
EBITDA Margin0.00%
Profit Margin-155404.38%
ROE354.96%
ROA-2200.93%
Growth
Revenue Growth—
Earnings Growth—
Cash Flow & Leverage
Operating CF-20.36M USD
CapEx (TTM)500.00K USD
FCF Margin—
FCF Yield-1.34%
Net Debt207.45K USD
Net Debt/EBITDA—
Balance Sheet
Debt/Equity-0.36
Current Ratio0.13
Quick Ratio0.02
Book Value/Sh-0.5480 USD
Cash/Share0.0050 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating1.3 (Strong Buy)
Target (Mean)16.00 USD
Target Range13.00 USD – 20.00 USD
# Analysts3
Ownership
Shares Out.26.01M
Float7.99M
Insiders56.68%
Institutions11.25%
Short Interest
Short Ratio2.3d
Short % Float2.00%
Short % Out.0.90%
Shares Short234.20K
Short (prev mo.)363.97K
Technical
SMA 505.644 (-18.5%)
SMA 2008.247 (-44.2%)
Beta—
S&P 52W Chg27.94%
Avg Vol (30d)91.08K
Avg Vol (10d)52.71K
Technical Indicators
RSI (14)38.2
MACD-0.1737
MACD Signal-0.1501
MACD Hist.-0.0235
BB Upper6.277 USD
BB Middle5.217 USD
BB Lower4.157 USD
BB Width40.63%
ATR (14)0.5054 USD
Vol Ratio (20d)0.22x